BamSEC and AlphaSense Join Forces
Learn More

Vyome Holdings Inc. – Material Contracts

NASDAQ: HIND    
Share price (3/27/26): $2.13    
Market cap (3/27/26): $14.9 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.45
from 10-K 2 pages Amendment No. 1 to Notes Purchase and Exchange Agreement
12/34/56
EX-10.23
from 10-K 2 pages Amendment to Employment Agreement, Dated July 8, 2024, by and Between Reshape Lifesciences Inc
12/34/56
EX-10.22
from 10-K 2 pages Office Service Agreement Dated June 27, 2024 Between Regus Management Group, LLC and Vyome Therapeutics, Inc
12/34/56
EX-10.21
from 10-K 2 pages Renewal Service Agreement Dated May 23, 2024 Between Regus Management Group, LLC and Vyome Therapeutics, Inc
12/34/56
EX-10.1
from 8-K 35 pages Notes Purchase and Exchange Agreement by and Among Livechain, Inc.; Lich Ai, Inc. and Remus Capital Series B II, L.P
12/34/56
EX-10.1
from 8-K 5 pages December 17, 2025 Attn: Venkat Nelabhotla Co-Founder, President & CEO Vyome Holdings, Inc Harvard Square, One Mifflin Place Suite 400, Cambridge Ma 02138 USA via Email: ALISON.FORSYTHE@HUMANYZE.com Re: Binding Letter of Intent Dear Mr. Nelabhotla
12/34/56
EX-10.1
from 8-K 8 pages Interim Full-Time Chief Financial Officer Consulting Agreement
12/34/56
EX-10.1
from 8-K 4 pages Vyome Therapeutics, Inc. Promissory Note
12/34/56
EX-10.1
from 8-K 21 pages Placement Agency Agreement June 8, 2025
12/34/56
EX-10.40
from S-4/A 17 pages License and Non-Stocking Distribution Agreement
12/34/56
EX-10.1
from 425 5 pages Vyome Therapeutics, Inc. Promissory Note
12/34/56
EX-10.1
from 8-K 5 pages Vyome Therapeutics, Inc. Promissory Note
12/34/56
EX-10.8
from 10-K 22 pages ReShape Lifesciences Employment Agreement
12/34/56
EX-10.27
from S-1/A 38 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 5 pages Re: Amendment No. 1
12/34/56
EX-10.26
from S-1 44 pages Equity Purchase Agreement
12/34/56
EX-10.32
from S-4/A 18 pages Development & Licensing Agreement
12/34/56
EX-10.31
from S-4/A 3 pages Addendum to Supply and Marketing Agreement
12/34/56
EX-10.30
from S-4/A 3 pages To, Sun Pharmaceutical Industries Limited Sun House, 201 8/1, Western Express Highway, Goregaon East, Mumbai- 400063 ​ Sub: Consent to Assignment Ref: Supply and Marketing Agreement Dated 10th Day of October, 2016 Read With Assignment Agreement Dated 15th October, 2016 Executed Between Vyome Biosciences Private Limited (“Company”) and Sun Pharmaceutical Industries Limited (“Sun”) (Hereinafter Referred to as (“Agreement”). ​ Dear Sir/Madam, ​
12/34/56
EX-10.29
from S-4/A 20 pages Supply and Marketing Agreement
12/34/56